W

Wellington Management

Global asset management for institutional clients

Executive Assistant

Full-TimePosted on 10/19/2026
$60k - $110k+ Discretionary Corporate Bonus + Incentives
Senior, Expert
Boston, MA, USA
HybridEmployees work in the office four days a week, with flexibility to work remotely one day a week.
Administrative & Executive AssistanceExecutive Support
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A minimum of 5–10 years of experience as an Executive Assistant or senior administrative professional, including demonstrated experience supporting senior leaders in specialized, operationally complex organizations.
  • Comfort supporting leaders in fast-paced, fast-changing, matrixed organizations.
  • Strong critical-thinking and problem-solving skills, with the ability to anticipate needs and act independently.
  • High emotional intelligence and the ability to remain flexible, composed, and positive amid shifting priorities and ambiguity.
  • Advanced proficiency in Microsoft Office, including Outlook, Word, Excel, and PowerPoint, and enthusiasm for adopting new tools and technologies, including AI-enabled solutions, to improve efficiency.
  • Exceptional organizational skills, attention to detail, and commitment to high-quality work.
  • A high degree of professionalism, integrity, and discretion when handling confidential information.
  • Outstanding interpersonal and communication skills, a service-oriented and collaborative approach, and the ability to build strong relationships and represent leaders well.
Responsibilities
  • Manage the overall daily support needs of the Chief Technology Officer and members of the leadership team.
  • Proactively manage complex and evolving calendars across multiple time zones, anticipating conflicts and prioritization needs in a fast-moving technology environment.
  • Coordinate logistics for internal and external meetings, including in-person, hybrid, and virtual sessions; prepare materials and ensure seamless execution.
  • Manage domestic and international travel arrangements when required, prepare detailed itineraries, and resolve issues quickly and independently.
  • Coordinate documentation and preparation of business-related expense reporting and departmental purchase order entry.
  • Act as a point of contact for internal and external stakeholders, exercising sound judgment and discretion when handling sensitive or time-critical matters.
  • Support team operations by preparing materials, tracking action items, and helping leaders maintain focus on priorities.
  • Leverage technology and AI-enabled tools to streamline workflows, improve organization, and enhance efficiency across administrative and operational tasks.
  • Assist with onboarding and offboarding activities, and maintain team documentation, shared drives, and process materials.
  • Provide cross-coverage and backup support to other Executive Assistants as needed.
  • Manage and coordinate logistics for department-wide initiatives, including town halls, holiday celebrations, and recognition of significant personal and professional milestones.
Desired Qualifications
  • Familiarity with agile, product, or iterative delivery models.

About the company

Wellington Management is a global investment management firm that offers equity, fixed income, multi-asset, and alternative investments to both institutional clients (such as pension funds, endowments, foundations, and insurers) and individual investors. It manages assets on behalf of clients, earning fees based on assets under management (AUM) and on investment performance. The firm relies on deep research capabilities and market insights to tailor investment strategies that meet client needs, and it integrates environmental, social, and governance (ESG) factors into its process. What sets Wellington Management apart is its broad suite of investment options combined with a commitment to ESG integration and a client-tailored approach, supported by a culture that emphasizes diversity and inclusion. The company’s goal is to help clients achieve their investment objectives by delivering disciplined, research-driven strategies and sustainable investing over the long term.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

$65.7B

Headquarters

Boston, Massachusetts

Founded

1933

Get referred to Wellington Management

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Hartford Funds acquisition closes in first quarter 2027, adding wealth distribution.
  • The new Wellington-Vanguard-Blackstone solutions expand access to public-private portfolios.
  • Wellington’s venture, biotech, climate, and CLO launches broaden fee-bearing alternatives.

What critics are saying

  • Hartford Funds integration carries execution risk until regulators approve the Q1 2027 close.
  • Steve Klar’s retirement in June 2026 exposes client-platform succession risk.
  • Passive giants and private-credit rivals compress Wellington’s fees and threaten AUM growth.

What makes Wellington Management unique

  • Wellington blends public and private markets through alliances with Vanguard and Blackstone.
  • Its $1.35 trillion platform spans 60 countries and over 2,500 institutional clients.
  • Matt Witheiler’s Forbes Midas List streak validates Wellington’s late-stage growth investing credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Comprehensive health coverage
  • Work-life balance
  • Financial future
  • Development

Company News

The Information
Oct 15th, 2026
Mueon raises $65M to pack up to 10x more AI computing into data centres

Portland-based startup Mueon has raised $65 million to develop a new way to arrange AI server rack components. The company says its design could fit up to 10 times more computing capacity into the same amount of power as existing data centre setups. The approach could ease constraints on global computing capacity.

Business Wire
Oct 13th, 2026
Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program

Edgewise Therapeutics, a clinical-stage biopharmaceutical company developing orally bioavailable, small molecule therapies for musculoskeletal diseases, toda...

MarketScreener
Oct 13th, 2026
Alaunos Therapeutics to raise $350M in private placement led by Fairmount

Alaunos Therapeutics has agreed to raise about $349.95 million through a private placement of stock. It signed a Securities Purchase Agreement to sell 687,789 shares of common stock at $1.4357 per share and 243,063 shares of Series C preferred stock at $1,435.70 per share. The common stock brings in about $987,459, and the preferred stock about $348.97 million. The deal is expected to close on October 14, 2026, subject to customary closing conditions. Fairmount led the placement of Series C non-voting convertible preferred stock. Venrock Healthcare Capital Partners, T. Rowe Price Investment Management, Wellington Management, Janus Henderson Investors, Access Biotechnology, BB Biotech, Perceptive Advisors, Sirenia Capital Management, ADAR1 Capital Management and other firms took part.

LinkedIn
Sep 30th, 2026
We just closed an employee tender offer which values ElevenLabs at $22BN, up 2x from our Series D in February. The tender was led by Wellington and T. Rowe Price, and the growth is driven by demand… | Mati Staniszewski | 89 comments

We just closed an employee tender offer which values ElevenLabs at $22BN, up 2x from our Series D in February. The tender was led by Wellington and T. Rowe Price, and the growth is driven by demand from enterprises to deploy ElevenAgents across sales, support, and operations. In 2022, we raised our first round at a $9 million valuation, which we announced alongside Eleven v1, our first Text to Speech model, and the first model to generate human-level speech. Four years later, as we reach our new valuation, we just released two new state-of-the-art Text to Speech models. Eleven v4 and v4 Turbo are our fastest and most emotive models yet, and are leading independent benchmarks. Alongside models, we have built a full interaction platform for AI. It allows organizations to deploy conversational agents, connected to their knowledge and systems, that interact naturally in any industry, geography, or context. This shift is driving much of our growth, with enterprise now accounting for 55% of our revenue, as businesses adopt ElevenAgents to support their customers and employees. Our technology is now used in daily operations at five of the world’s ten largest tech companies, five of the ten largest insurers, and four of the ten largest telecoms. The round was co-led by Wellington Management and T. Rowe Price, along with participation from Goldman Sachs, GIC, Ontario Teachers'​ Pension Plan, EQT Group, Sapphire Ventures, and BDT & MSD Partners. And grateful for ongoing support from existing investors including Andreessen Horowitz, Alkeon Capital, The D. E. Shaw Group, Disruptive, Evantic Capital, ICONIQ, and Lightspeed. Most of all, this round is for the team that built the last four years. We're just getting started! | 89 comments on LinkedIn

MarketScreener
Sep 29th, 2026
Immix Biopharma prices $125M stock offering to fund AL amyloidosis therapy development

Immix Biopharma has priced an underwritten public offering of 11,363,637 shares of common stock at $11.00 per share, expecting gross proceeds of $125 million before deducting underwriting discounts and expenses. The offering is expected to close on or about 30 September 2026. The company intends to use the net proceeds to fund development of NXC-201, working capital, and general corporate purposes. NXC-201 is a CAR-T cell therapy being evaluated for relapsed/refractory AL Amyloidosis and has received Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy designation from the US FDA. J.P. Morgan is acting as sole book-running manager. The offering included participation from institutional investors including Eventide Asset Management, Janus Henderson Investors, Ridgeback Capital Investments, and Wellington Management.